Pajson Agro India's IPO Fund Use Faces Scrutiny Amidst Delays

Pajson Agro India Limited has used ₹24.14 crore of its ₹74.45 crore IPO proceeds as of March 31, 2026. CARE Ratings, in its monitoring report, highlighted concerns regarding spending on General Corporate Purposes (GCP) exceeding limits and delays in the Vizianagaram facility's capital expenditure, noting a shortfall for FY26.

Monitoring Report Details Fund Use

Pajson Agro India Limited submitted its Monitoring Agency Report for the half-year ending March 31, 2026. CARE Ratings prepared this report, detailing how the company's ₹74.45 crore raised from its Initial Public Offering (IPO) has been utilized. By the reporting date, ₹24.14 crore had been spent, leaving ₹50.31 crore unutilized. The report specifically noted that spending allocated to General Corporate Purposes (GCP) surpassed the stipulated ₹10 crore limit, reaching ₹10.34 crore. Additionally, delays were recorded in the capital expenditure for the Vizianagaram facility, with a ₹13.22 crore shortfall reported for FY26.

Investor Scrutiny Amidst Concerns

Investors closely watch IPO fund deployment as it indicates planned growth and capital allocation efficiency. Exceeding GCP limits and project delays can signal potential execution challenges or operational concerns. The report from CARE Ratings prompts questions about the company's financial discipline and project management effectiveness.

About Pajson Agro India

Pajson Agro India Limited is engaged in the processing and marketing of cashew kernels and cashew nut shell liquid (CNSL). The company conducted its IPO, raising ₹74.45 crore, from December 11-15, 2025.

Outlook for Shareholders

Shareholders will be looking for the company's efforts to address the identified issues with fund deployment. There will likely be increased focus on Pajson Agro's adherence to its stated business plan and financial commitments. Closer monitoring by CARE Ratings and other stakeholders on future progress is also anticipated.

Key Risks Identified

Potential risks include further regulatory attention if approvals for the excess GCP spending are not obtained. Ongoing delays at the Vizianagaram facility could impede planned capacity expansion and affect revenue targets. The company also faces reputational risk should these operational or financial discipline issues continue.

Key Financial Figures

• Total IPO proceeds: ₹74.45 crore
• Amount utilized by March 31, 2026: ₹24.14 crore
• General Corporate Purposes allocation: Revised to ₹10.43 crore; ₹10.34 crore utilized (FY25-FY26)
• Vizianagaram facility capex utilized by March 31, 2026: ₹6.78 crore (original cost ₹57.00 crore)

Next Steps for Investors

Investors should monitor the company's progress in securing necessary approvals for the Vizianagaram facility. Management's strategy for overcoming project delays and resource shortages will also be a key focus. Any further clarifications from Pajson Agro regarding the GCP overspend and subsequent updates from CARE Ratings on the company's compliance will be important.